KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
$5.03
+0.150 (+3.07%)
At Close: Apr 26, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $4.61 $7.24 Friday, 26th Apr 2024 AFMD stock ended at $5.03. This is 3.07% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 6.35% from a day low at $4.88 to a day high of $5.19.
90 days $4.25 $7.24
52 weeks $2.24 $11.10

Historical Affimed N.V. prices

Date Open High Low Close Volume
Jun 06, 2022 $31.30 $31.80 $27.90 $28.20 150 219
Jun 03, 2022 $31.10 $32.40 $30.35 $31.00 110 415
Jun 02, 2022 $31.20 $31.88 $30.70 $30.95 120 390
Jun 01, 2022 $31.10 $32.10 $29.20 $31.30 157 171
May 31, 2022 $33.10 $33.10 $30.40 $31.00 94 956
May 27, 2022 $31.50 $32.45 $30.58 $32.00 123 353
May 26, 2022 $31.80 $32.80 $31.35 $31.50 113 830
May 25, 2022 $31.30 $32.00 $30.80 $31.70 70 860
May 24, 2022 $32.20 $32.40 $30.90 $31.20 90 549
May 23, 2022 $33.20 $34.00 $32.50 $32.70 107 596
May 20, 2022 $34.50 $35.30 $31.49 $32.80 185 453
May 19, 2022 $32.40 $34.50 $32.19 $34.00 246 820
May 18, 2022 $34.10 $35.10 $32.00 $32.60 186 077
May 17, 2022 $33.70 $35.20 $33.35 $35.10 73 404
May 16, 2022 $32.40 $34.10 $32.20 $32.80 86 618
May 13, 2022 $31.30 $33.20 $31.30 $32.70 186 177
May 12, 2022 $28.80 $31.70 $28.80 $30.70 265 373
May 11, 2022 $32.10 $32.75 $29.20 $29.30 211 650
May 10, 2022 $31.60 $33.40 $31.05 $32.40 176 044
May 09, 2022 $33.80 $34.20 $29.90 $30.40 343 995
May 06, 2022 $37.40 $37.70 $33.90 $34.20 175 223
May 05, 2022 $39.50 $39.60 $36.80 $37.80 127 931
May 04, 2022 $38.90 $40.00 $37.10 $39.90 131 261
May 03, 2022 $39.80 $40.10 $38.25 $39.10 127 652
May 02, 2022 $37.70 $39.50 $37.40 $39.50 114 055
Click to get the best stock tips daily for free!

About Affimed N.V.

Affimed N.V. Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in Phase I clinical trial for hodgkin lymphoma. The company is also developing AFM24, a tetravalent, bispec... AFMD Profile

Golden Star

Ticker Date Change Price
DHT Apr 24 2.04% $11.28
MLI Apr 19 9.66% $52.28
LPLA Apr 19 1.42% $262.59
DOOR Apr 18 0.167% $131.39
LNG Apr 17 1.49% $156.81
FCN Apr 16 1.80% $207.62
ELV Apr 16 5.97% $506.97
AKR Apr 05 4.78% $16.53
ITCI Apr 05 7.04% $68.44
VSTS Apr 04 0.425% $18.82
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT